Literature DB >> 8037212

Linkage disequilibrium and haplotype studies of chromosome 8p 11.1-21.1 markers and Werner syndrome.

C E Yu1, J Oshima, K A Goddard, T Miki, J Nakura, T Ogihara, M Poot, H Hoehn, M Fraccaro, C Piussan.   

Abstract

Werner syndrome (WS) is an autosomal recessive disorder, characterized as a progeroid syndrome, previously mapped to the 8p 11.1-21.1 region. Because WS is so rare, and because many patients are from consanguineous marriages, fine localization of the gene by traditional meiotic mapping methods is unlikely to succeed. Here we present the results of a search for a region that exhibits linkage disequilibrium with the disorder, under the assumption that identification of such a region may provide an alternative method of narrowing down the location of WRN, the gene responsible for WS. We present allele frequencies in Japanese and Caucasian cases and controls for D8S137, D8S131, D8S87, D8S278, D8S259, D8S283, fibroblast growth factor receptor 1, ankyrin 1, D8S339, and two polymorphisms in glutathione reductase (GSR), covering approximately 16.5 cM in total. We show that three of the markers examined--D8S339 and both polymorphisms in the GSR locus--show strong statistically significant evidence of disequilibrium with WRN in the Japanese population but not in the Caucasian population. In addition, we show that a limited number of haplotypes are associated with the disease in both populations and that these haplotypes define clusters of apparently related haplotypes that may identify as many as eight or nine independent WRN mutations in these two populations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037212      PMCID: PMC1918357     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  26 in total

1.  Homozygosity mapping and Werner's syndrome.

Authors:  G D Schellenberg; G M Martin; E M Wijsman; J Nakura; T Miki; T Ogihara
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

2.  A second-generation linkage map of the human genome.

Authors:  J Weissenbach; G Gyapay; C Dib; A Vignal; J Morissette; P Millasseau; G Vaysseix; M Lathrop
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

3.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

4.  A genetic analysis of the Werner syndrome region on human chromosome 8p.

Authors:  W Thomas; M Rubenstein; M Goto; D Drayna
Journal:  Genomics       Date:  1993-06       Impact factor: 5.736

5.  Detection of linkage disequilibrium between the myotonic dystrophy locus and a new polymorphic DNA marker.

Authors:  H G Harley; J D Brook; J Floyd; S A Rundle; S Crow; K V Walsh; M C Thibault; P S Harper; D J Shaw
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

6.  Fine genetic mapping of the Batten disease locus (CLN3) by haplotype analysis and demonstration of allelic association with chromosome 16p microsatellite loci.

Authors:  H M Mitchison; A D Thompson; J C Mulley; H M Kozman; R I Richards; D F Callen; R L Stallings; N A Doggett; J Attwood; T R McKay
Journal:  Genomics       Date:  1993-05       Impact factor: 5.736

7.  Human chromosome 8 linkage map based on short tandem repeat polymorphisms: effect of genotyping errors.

Authors:  J Tomfohrde; S Wood; M Schertzer; M J Wagner; D E Wells; J Parrish; L A Sadler; S H Blanton; S P Daiger; Z Wang
Journal:  Genomics       Date:  1992-09       Impact factor: 5.736

Review 8.  The Huntington's disease candidate region exhibits many different haplotypes.

Authors:  M E MacDonald; A Novelletto; C Lin; D Tagle; G Barnes; G Bates; S Taylor; B Allitto; M Altherr; R Myers
Journal:  Nat Genet       Date:  1992-05       Impact factor: 38.330

9.  Genetic linkage of Werner's syndrome to five markers on chromosome 8.

Authors:  M Goto; M Rubenstein; J Weber; K Woods; D Drayna
Journal:  Nature       Date:  1992-02-20       Impact factor: 49.962

10.  Additional polymorphisms at marker loci D9S5 and D9S15 generate extended haplotypes in linkage disequilibrium with Friedreich ataxia.

Authors:  R Fujita; A Hanauer; G Sirugo; R Heilig; J L Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

View more
  7 in total

1.  Toward localization of the Werner syndrome gene by linkage disequilibrium and ancestral haplotyping: lessons learned from analysis of 35 chromosome 8p11.1-21.1 markers.

Authors:  K A Goddard; C E Yu; J Oshima; T Miki; J Nakura; C Piussan; G M Martin; G D Schellenberg; E M Wijsman
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

2.  Mutations in the consensus helicase domains of the Werner syndrome gene. Werner's Syndrome Collaborative Group.

Authors:  C E Yu; J Oshima; E M Wijsman; J Nakura; T Miki; C Piussan; S Matthews; Y H Fu; J Mulligan; G M Martin; G D Schellenberg
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

Review 3.  The role of RecQ helicases in non-homologous end-joining.

Authors:  Guido Keijzers; Scott Maynard; Raghavendra A Shamanna; Lene Juel Rasmussen; Deborah L Croteau; Vilhelm A Bohr
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-07-22       Impact factor: 8.250

4.  Acetylation of Werner protein at K1127 and K1117 is important for nuclear trafficking and DNA repair.

Authors:  Deblina Ghosh; Vilhelm A Bohr; Parimal Karmakar
Journal:  DNA Repair (Amst)       Date:  2019-05-03

5.  Structure and function of the human Werner syndrome gene promoter: evidence for transcriptional modulation.

Authors:  L Wang; K E Hunt; G M Martin; J Oshima
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

Review 6.  From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing.

Authors:  L S Cox; R G A Faragher
Journal:  Cell Mol Life Sci       Date:  2007-10       Impact factor: 9.261

7.  WRN polymorphisms affect expression levels of plasminogen activator inhibitor type 1 in cultured fibroblasts.

Authors:  Elena Castro; Vladimir Oviedo-Rodríguez; Luis I Angel-Chávez
Journal:  BMC Cardiovasc Disord       Date:  2008-02-29       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.